OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Julie Gralow on Why Federal Funding Matters for the Future of Cancer Research

ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps

Alejandra Mendez Highlights the Impact of the Zero Abandonment Programme in Childhood Cancer

Medical Oncology vs Radiation Oncology: Who Does What in Cancer Care?

Shane Jacobson: New $5.45 Million Fund to Empower the Next Generation of Cancer Scientists

Oncology News, Insights, Stories by OncoDaily

Daiichi Sankyo
OncoIndustry

Daiichi Sankyo and AstraZeneca’s Enhertu Plus Pertuzumab Approved in China for First-Line HER2+ Metastatic Breast Cancer

FDA
Voices

FDA is Announcing an Upcoming Meeting

Financial Toxicity
Community

Financial Toxicity in Cancer Care: A Global Call for Submissions

Five-Year CheckMate 648 Follow-Up: Nivolumab-Based Therapy in Advanced ESCC

Kevin Harrington: FDA Approval Marks a Major Breakthrough for RP1

10 Must-Read Posts In Radiotherapy This Week: August 2 -9

Ada Waks: Therapeutic Strategy for CDK4/6i-Resistant HR+ Metastatic Breast Cancer

Nazik Hammad: How Does Africa Produce Its Medical Oncology Workforce Locally?

HPV Vaccination After Cervical Intraepithelial Neoplasia: A New Era of Prevention in Brazil

Fabio Ynoe Moraes: Managing Brain-Only Progression in Extensive-Stage SCLC

Voices
Harpreet Singh

Harpreet Singh։ Dose Optimization in Oncology Radiopharmaceutical Therapies

Ashley Sumrall Credits Federally Funded Clinical Trial Findings for Improving Brain Tumor Care - ASCO

Gwen Nichols։ Peer Review Works for Blood Cancer Research and Patients

Michael Fradley։ Arrhythmias in Cardio-Oncology and Pathways to Reduce Heart Failure in Patients With Cancer

ARCCS Team Comes Together to Shape Priorities for Cancer Survivorship Research

Nosakhare Paul Ilerhunmwuwa Receives 2026 Resident/Fellow Award for Advanced Melanoma Research - MRF

ASCO Opens Applications for 2027–28 Leadership Development Program

FDA Approvals
FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

Germline Predisposition and Acute Leukemia - Resonance

Acute Leukemia Research and Care Network (ALRCaN)

14 Aug
Germline Predisposition

The Meningioma Symposium 2026

Wiener Medizinische Akademie (WMA)

28 Sep
Meningioma Symposium

The 31st Annual Meeting and Education Day of the Society for Neuro-Oncology - SNO 2026

Society for Neuro-Oncology (SNO)

12 Nov
Society for Neuro-Oncology

The IBRI Global Forum

Indiana Biosciences Research Institute (IBRI)

29 Oct
IBRI Global Forum

FDA Panel Review of GRAIL’s Galleri Test

U.S. Food and Drug Administration (FDA)

23 Sep
GRAIL’s Galleri

Immune-oncology
PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Hypoxia and Immunotherapy Resistance: Can HIF Targeting Improve Response?

In Vivo CAR-T Cell Therapy: Clinical Proof of Concept and the Rising Role of AI

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Can Diet and the Gut Microbiome Improve Immunotherapy Response?

Tumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy

Gastrointestinal-Oncology
NETTER-2

NETTER-2: First-Line [177Lu]Lu-DOTA-TATE plus Octreotide in Advanced G2-G3 GEP-NETs

Daraxonrasib Resistance in Pancreatic Cancer Points to New Combination Strategies

Five-Year CheckMate 648 Follow-Up: Nivolumab-Based Therapy in Advanced ESCC

Liver Transplantation After Chemotherapy and SIRT in Unresectable iCCA

10 Must-Read Posts In GI Oncology This Week

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

EvIDHence Study: Real-World Outcomes in IDH1-Mutant and Wild-Type Cholangiocarcinoma Before mIDH1 Inhibitors

Breast-Oncology
Rb

Rb-Driven Transcription Reveals a CDK4/6 Paradox in Breast Cancer

ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps

Germline BRCA1 Variants May Impair T Cell Function in Breast Cancer

Radiotherapy in Breast Cancer LMD: Critical Survival Uncertainty

After T-DXd: Why Switching ADC Targets May Not Be Enough

HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer

Patient-Reported GI Toxicity Reveals Hidden Burden With Neratinib Plus T-DM1

Lung-Oncology
Air Pollution

Air Pollution and Lung Cancer: Critical Metabolic Clues

Transformed SCLC in EGFR-Mutant NSCLC: Critical Progress in a High-Risk Setting

TP53-Mutated EGFR NSCLC: Powerful PFS Gain With Combination Therapy

Targeted Therapy Resistance in NSCLC: Critical Next Steps

SKYSCRAPER-03 Trial: Critical Setback for TIGIT Consolidation in Stage III NSCLC

HER2 Mutations in NSCLC: Critical Risks of Outdated Terms

EGFR Amplification in EGFR-Mutated NSCLC: Critical Risk Marker

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
Artificial Intelligence in Leukemia Diagnosis LeukO 2026

Artificial Intelligence and Digital Pathology in Leukemia Diagnosis

Treatment-Free Remission (TFR) in CML: Who, When, and How?

The Next Frontier in R/R ALL: CAR-T, Bispecifics, and Emerging Strategies

Hematologic Malignancies: Therapeutic Success Amid Epidemiological Failure

Hairy Cell Leukemia (HCL): A Rare Leukemia Treated Well, but Rarely Eradicated

Extramedullary Disease in Multiple Myeloma (EMD): Progress in the Immunotherapy Era

Access to TCRTs in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives

Radiotherapy
TREASURE

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

ESTRO Breast Radiotherapy Target Volumes Prospectively Validated in DBCG Skagen Trial 1

10 Must-Read Posts In Radiotherapy This Week: August 2 -9

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

OncoDaily TV
Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Not To Miss
Emirates Oncology Society

The 7th Emirates Oncology Society Annual Conference 2026

ACS National Lung Cancer Roundtable Sets Priorities for Advanced Imaging in Lung Cancer

Top 10 OncoGrants This Week: Major Funding Opportunities Across Cancer Research

ACS CAN Warns New U.S. Vaccine Order Could Put Cancer Patients and Survivors at Risk

LeukO 2026 to Unite the Global Leukemia Community This September

VIRO 2026 Brings Global Voices Together in Renal Oncology

Novo Nordisk and Amazon Web Services Partner to Accelerate Drug Discovery Through AI

OncoGrants
Therapeutic Catalyst

Cancer Research Horizons Childhood Cancer Therapeutic Catalyst 2026

Therapeutic Catalyst

Cancer Research UK Therapeutic Catalyst Awards 2026

KI–Mayo Clinic

Cancer Research KI–Mayo Clinic CCC Synergy Grants 2027–2031

Blue Sky Grant

Cancer Research KI Blue Sky Grant for Innovative Cancer Research and Technology 2026

Professor Award

American Cancer Society Professor Award 2026

ASTRO–ACS

ASTRO–ACS Clinician Scientist Development Grant 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Rony Dev

Rony Dev

Oncologists Location Houston, USA
Verna Vanderpuye

Verna Vanderpuye

Oncologists Location Accra, Ghana
Salvatore Provenzano

Salvatore Provenzano

Oncologists Location Milan, Italy
Gaurav Narula

Gaurav Narula

Oncologists Location Mumbai, India
Subhadarsini Mohapatra

Subhadarsini Mohapatra

Oncologists Location Thiruvananthapuram, India
Dinesh Pendharkar

Dinesh Pendharkar

Oncologists Location Faridabad, India
Yizhuo Zhang

Yizhuo Zhang

Oncologists Location Guangzhou, China
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries